Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » PCR » Cadex Genomics Developing Liquid Biopsy-Based Test for Early Response to Cancer Therapies

Cadex Genomics Developing Liquid Biopsy-Based Test for Early Response to Cancer Therapies

Feb 27, 2019
|
Leo O'Connor
Premium

NEW YORK (GenomeWeb) — Startup Cadex Genomics expects to soon launch a laboratory-developed test that uses a real-time quantitative PCR liquid biopsy assay with retrotransposon-based quantification technology to analyze the variable length of DNA fragments from cancer cells and provide clinicians with a tool to evaluate how cancer patients diagnosed with stage IV solid tumors are responding initially to treatment. 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Technical, But Key Meeting

Independent advisors to the US Food and Drug Administration are to meet this week to discuss how they will make SARS-CoV-2 vaccine recommendations, the Washington Post reports.

Spinning an FDA "Cocoon"

The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.

Gene for When to Go

Researchers have identified a gene involved in how people determine when to urinate.

Genome Research Papers on Chromatin Accessibility, Malaria Mosquitoes, Bacterial Pan-Genome Method

In Genome Research this week: assay for profiling chromatin accessibility, analysis of genetic variants among malaria-transmitting mosquitoes, and more.

Oct
28
Featured Webinar

How Low Can You Go? Reduce Breeding Costs with an Optimized Genotyping and Analysis Strategy

Sponsored by
NRGene

Molecular breeding methods such as genomic selection and genome-wide association studies often require high-density genotypic data from many samples, but the cost and complexity of genotyping at this scale may be prohibitive.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov
05
Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

Sponsored by
Roche

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In PCR

  1. Thermo Fisher Scientific Q3 Revenues Soar 36 Percent

  2. BD, CerTest Biotec Get CE-IVD Mark for Combination COVID-19, Influenza, RSV Test on BD Max

  3. Thermo Fisher Scientific Continues to See Strong Demand for Pandemic-Related Products and Services

    Premium

  4. Interdisciplinary NIST Team Claims qPCR Improvements Using Unusual Math Tweaks

    Premium

  5. Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.